Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Vaccine Type
2.3.2 Market Size By Route of Administration
2.3.3 Market Size By Age Group
2.3.4 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1. Antigen, Adjuvant & Raw Material Suppliers
3.4.2. Vaccine Manufacturers & Fill-Finish Service Providers
3.4.3. Distributors, Cold Chain & Logistics Providers
3.4.4. Public Health Programs, Hospitals, Clinics & Pharmacies
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Vaccination Coverage & Immunization Metrics
4.1.1 Global Typhoid Fever Vaccine Doses Administered Annually
4.1.2 Routine Immunization vs. Campaign-Based Coverage Rates
4.1.3 Number of Countries Introducing TCV into National Programs
4.1.4 Vaccine Coverage by Age Group and Geographic Region
4.2 Disease Burden & Epidemiology Statistics
4.2.1 Estimated Global Typhoid Fever Incidence and Case Volumes
4.2.2 Antimicrobial-Resistant Typhoid Case Statistics
4.2.3 Outbreak Frequency and Geographic Distribution Metrics
4.2.4 Mortality and Complication Rates by Endemic Region
4.3 Vaccine Procurement, Supply & Pricing Economics
4.3.1 Global Vaccine Procurement Volumes by Buyer Type
4.3.2 Average Vaccine Price per Dose by Vaccine Type
4.3.3 Gavi, UNICEF and Public-Sector Procurement Metrics
4.3.4 Manufacturing Capacity and Supply Availability Statistics
4.4 Clinical Performance & Effectiveness Benchmarks
4.4.1 Vaccine Efficacy and Immunogenicity Benchmarks by Type
4.4.2 Duration of Protection and Booster Requirement Metrics
4.4.3 Safety and Adverse Event Reporting Rates
4.4.4 Real-World Effectiveness and Post-Marketing Surveillance Data
4.5 Technology, Quality & Innovation Indicators
4.5.1 Conjugate vs. Vi-PS vs. Live Attenuated Technology Adoption
4.5.2 WHO Prequalification and Regulatory Approval Statistics
4.5.3 Cold Chain and Thermostability Performance Metrics
4.5.4 Product Launches, Patent Filings and Technology Development Activity
5. Typhoid Fever Vaccines Market Segmental Analysis & Forecast, By Vaccine Type, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Conjugate (TCV)
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Vi Polysaccharide (Vi-PS)
5.4 Live Attenuated Ty21a
5.5 Other Vaccine Types
6. Typhoid Fever Vaccines Market Segmental Analysis & Forecast, By Route of Administration, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Injectable
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Oral
7. Typhoid Fever Vaccines Market Segmental Analysis & Forecast, By Age Group, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 6 Months to Less Than 2 Years
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 2 to 5 Years
7.4 6 to 15 Years
7.5 More Than 15 Years
8. Typhoid Fever Vaccines Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Public Health & Government Programs
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Hospitals & Clinics
8.4 Travel & Retail Clinics and Pharmacies
9. Typhoid Fever Vaccines Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Typhoid Fever Vaccines Market Size & Forecast, By Vaccine Type, 2022–2035
9.2.3 Typhoid Fever Vaccines Market Size & Forecast, By Route of Administration, 2022–2035
9.2.4 Typhoid Fever Vaccines Market Size & Forecast, By Age Group, 2022–2035
9.2.5 Typhoid Fever Vaccines Market Size & Forecast, By End User, 2022–2035
9.2.6 Typhoid Fever Vaccines Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Typhoid Fever Vaccines Market Size & Forecast, By Vaccine Type, 2022–2035
9.3.3 Typhoid Fever Vaccines Market Size & Forecast, By Route of Administration, 2022–2035
9.3.4 Typhoid Fever Vaccines Market Size & Forecast, By Age Group, 2022–2035
9.3.5 Typhoid Fever Vaccines Market Size & Forecast, By End User, 2022–2035
9.3.6 Typhoid Fever Vaccines Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Typhoid Fever Vaccines Market Size & Forecast, By Vaccine Type, 2022–2035
9.4.3 Typhoid Fever Vaccines Market Size & Forecast, By Route of Administration, 2022–2035
9.4.4 Typhoid Fever Vaccines Market Size & Forecast, By Age Group, 2022–2035
9.4.5 Typhoid Fever Vaccines Market Size & Forecast, By End User, 2022–2035
9.4.6 Typhoid Fever Vaccines Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Typhoid Fever Vaccines Market Size & Forecast, By Vaccine Type, 2022–2035
9.5.3 Typhoid Fever Vaccines Market Size & Forecast, By Route of Administration, 2022–2035
9.5.4 Typhoid Fever Vaccines Market Size & Forecast, By Age Group, 2022–2035
9.5.5 Typhoid Fever Vaccines Market Size & Forecast, By End User, 2022–2035
9.5.6 Typhoid Fever Vaccines Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Mexico
9.5.6.3 Argentina
9.5.6.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Typhoid Fever Vaccines Market Size & Forecast, By Vaccine Type, 2022–2035
9.6.3 Typhoid Fever Vaccines Market Size & Forecast, By Route of Administration, 2022–2035
9.6.4 Typhoid Fever Vaccines Market Size & Forecast, By Age Group, 2022–2035
9.6.5 Typhoid Fever Vaccines Market Size & Forecast, By End User, 2022–2035
9.6.6 Typhoid Fever Vaccines Market Size & Forecast, By Country, 2022–2035
9.6.6.1 Saudi Arabia
9.6.6.2 South Africa
9.6.6.3 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Year-Wise Strategies & Development, 2022–2026
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Bharat Biotech International Limited
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 Geographical Presence
10.6.1.5 SWOT Analysis
10.6.2 Biological E. Limited
10.6.3 SK bioscience Co., Ltd.
10.6.4 Zydus Lifesciences Ltd.
10.6.5 Sanofi S.A.
10.6.6 Bavarian Nordic A/S
10.6.7 Serum Institute of India Pvt. Ltd.
10.6.8 PT Bio Farma (Persero)
10.6.9 EuBiologics Co., Ltd.
10.6.10 Bio-Med Pvt. Ltd.
10.6.11 Incepta Pharmaceuticals Ltd.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
Key players include Bharat Biotech International Limited, Biological E. Limited, Sanofi S.A. and PT Bio Farma (Persero), among others.
Key opportunities include bivalent typhoid-paratyphoid vaccines, regional manufacturing in Africa and South Asia, and thermostable formulations for remote settings.
The primary growth factor is the WHO and Gavi-backed rollout of typhoid conjugate vaccines, combined with rising drug-resistant typhoid in South Asia and Africa.
By vaccine type, the Vi Polysaccharide segment dominates the Typhoid Fever Vaccines Market with approximately 41.86% share in 2025.
Asia-Pacific dominates the Typhoid Fever Vaccines Market, while North America accounts for approximately 12.84% share in 2025.